Cormorant Asset Management, LP Tango Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.25 - $5.46 $1.27 Million - $2.13 Million	-390,894 Reduced 8.67%	4,116,949 $14.9 Million
Q2 2022 Aug 15, 2022	SELL	$3.86 - $8.01 $1.51 Million - $3.13 Million	-391,342 Reduced 7.99%	4,507,843 $20.4 Million
Q4 2021 Feb 14, 2022	BUY	$9.55 - $14.29 $9.55 Million - $14.3 Million	1,000,000 Added 25.65%	4,899,185 $53.1 Million
Q3 2021 Nov 15, 2021	BUY	$9.56 - $17.3 $37.3 Million - $67.5 Million	3,899,185 New	3,899,185 $48.8 Million

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $320M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.